These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27989428)

  • 1. San Antonio Breast Cancer Symposium 2016.
    Gourd K
    Lancet Oncol; 2017 Feb; 18(2):176. PubMed ID: 27989428
    [No Abstract]   [Full Text] [Related]  

  • 2. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in metastatic breast cancer from the 2013 San Antonio Breast Cancer Symposium (SABCS).
    O'Shaughnessy JA
    Clin Adv Hematol Oncol; 2014 Mar; 12(3 Suppl 7):3-17. PubMed ID: 24870974
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical utility of HER2-targeted therapy in the neoadjuvant setting: recent results from the San Antonio Breast Cancer Symposium.
    Abair T; O'Shaughnessy J
    Clin Breast Cancer; 2011 Feb; 11(1):15-9. PubMed ID: 21989832
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.
    Benson JR; Jatoi I
    Future Oncol; 2016 Apr; 12(7):897-900. PubMed ID: 26880386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. San Antonio Breast Cancer Symposium 2017.
    Nelson R
    Lancet Oncol; 2018 Jan; 19(1):22. PubMed ID: 29249305
    [No Abstract]   [Full Text] [Related]  

  • 7. San Antonio Breast Cancer Symposium--27th Annual Meeting.
    Susman E
    IDrugs; 2005 Jan; 8(1):21-4. PubMed ID: 15650936
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.
    Yan T; Yin W; Zhou Q; Zhou L; Jiang Y; Du Y; Shao Z; Lu J
    Eur J Cancer; 2012 Jan; 48(2):187-95. PubMed ID: 22100904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs in metastatic breast cancer: an update.
    Arslan C; Altundag K; Dizdar O
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):647-67. PubMed ID: 22122529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 29th Annual Meeting of the San Antonio Breast Cancer Symposium, TX, USA; Dec 14-18, 2006.
    Moyer P
    Lancet Oncol; 2007 Feb; 8(2):106. PubMed ID: 17288047
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant Therapy in Breast Cancer as a Basis for Drug Approval.
    Berry DA; Hudis CA
    JAMA Oncol; 2015 Oct; 1(7):875-6. PubMed ID: 26181139
    [No Abstract]   [Full Text] [Related]  

  • 12. Ribociclib in HR-positive, HER2-negative breast cancer.
    Burki TK
    Lancet Oncol; 2016 Nov; 17(11):e482. PubMed ID: 27746106
    [No Abstract]   [Full Text] [Related]  

  • 13. Ado-trastuzumab emtansine (Kadcyla) for HER2-positive metastatic breast cancer.
    Med Lett Drugs Ther; 2013 Sep; 55(1425):75-6. PubMed ID: 24662957
    [No Abstract]   [Full Text] [Related]  

  • 14. Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer.
    Boyraz B; Sendur MA; Aksoy S; Babacan T; Roach EC; Kizilarslanoglu MC; Petekkaya I; Altundag K
    Curr Med Res Opin; 2013 Apr; 29(4):405-14. PubMed ID: 23402224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of the San Antonio Breast Cancer Symposium 2016.
    Benson JR; Jatoi I
    Future Oncol; 2017 Jun; 13(15):1291-1295. PubMed ID: 28650276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of toremifene, a new antiestrogenic agent for the treatment of breast cancer. A symposium. San Antonio, TX, USA, December 7, 1989.
    Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S1-54. PubMed ID: 1980832
    [No Abstract]   [Full Text] [Related]  

  • 17. Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium.
    Fontanella C; Puglisi F
    Future Oncol; 2016; 12(8):1005-8. PubMed ID: 26856441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected highlights from the 26th San Antonio Breast Cancer Symposium. December 3-6, 2003, San Antonio, TX, USA.
    Montemurro F; Aglietta M
    Expert Opin Pharmacother; 2004 Apr; 5(4):981-9. PubMed ID: 15102581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus: a new hope for patients with breast cancer.
    Sendur MA; Zengin N; Aksoy S; Altundag K
    Curr Med Res Opin; 2014 Jan; 30(1):75-87. PubMed ID: 24050600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel in the management of breast and non-small-cell lung cancers. ASCO 2000, 22nd annual San Antonio Breast Cancer Symposium, and ECCO 10. Abstracts.
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 7):7-47. PubMed ID: 11021302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.